Galaxy Surfactants Ltd
Galaxy Surfactants Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management said on revenue, margins and capex.
Guidance rank: #67 of 68 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
What the Q1 FY27 call signalled
2 of 4 strong
The short version
Volume growth guidance maintained at 6% to 8% for full year FY26-27. Galaxy Surfactants expects volume growth of 6% to 8% annually going forward.
From Galaxy Surfactants Ltd's Q1 FY27 earnings-call transcript · updated 16 Oct 2026.
Revenue & Sales Performance
- Volume growth guidance maintained at 6% to 8% for full year FY26-27.
- Confident of sustaining 6% to 7% average volume growth beyond Q3-Q4 despite AMET market challenges.
- India region expected to continue strong volume growth, driven by rural demand and premiumization.
- Specialty ingredients and performance surfactants businesses both targeted for growth—no shift away from either.
- New specialty products pipeline expected to contribute over 5% of total revenue and margins by 2030.
- Inorganic growth pursued cautiously with acquisitions under evaluation, aiming for strategic fit and profitability accretion.
2 more points from Galaxy Surfactants Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Galaxy Surfactants Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Galaxy Surfactants plans a capex of about INR 150 crores for the current year, similar to the previous year.
- Some capex has already been front-loaded and commissioned, with the remainder to be commissioned this year.
- Capex is aimed at capacity expansions, including debottlenecking exercises, and preparing for anticipated business growth.
- There is a focus on growing both performance and specialty chemical segments.
- Inorganic growth via M&A is actively being evaluated; managment is seeking the right fit aligned with strategy and profitability.
- No planned acquisitions in the AMET market currently; any inorganic moves will be accretive and strategic.
2 more points from Galaxy Surfactants Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Galaxy Surfactants Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- It is mentioned that in the U.S. market, customer approvals and project approvals have started falling in place, indicating an improving order pipeline.
- The management highlighted good customer acceptance and project momentum, especially for new products like TRI-K and Everbond in the U.S. market.
- The momentum in demand remains healthy across key markets including India, U.S., and APAC.
2 more points from Galaxy Surfactants Ltd's call on order book
Create a free account to keep reading this call
Galaxy Surfactants Ltd — Quarterly revenue & net profit
Q1 FY27 figures are not in this chart yet. Latest shown: Mar 2026 (Q4 FY26). The Q1 FY27 numbers from the filing are in the analysis on this page.
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹1.3K Cr, net profit ₹62 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Galaxy Surfact.'s management said in earlier quarters
- Q2 FY26 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q4 FY25 earnings call analysis →
- Q4 FY26 earnings call analysis →
- Q1 FY26 earnings call →
- Q4 FY25 earnings call →
- Q3 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
Others in Chemicals & Petrochemicals this season
- Alufluoride (Q1 FY27)
Revenue from operations for Q1 FY27 was ₹26.6 crore, down 39% YoY (Page 6, 7, 8). Key investor presentation takeaways from Alufluoride Ltd's Q1 FY27 investor pr
- POCL Enterprises (Q1 FY27)
466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto
- Devson Catalyst (Q1 FY27)
FY 2023-24: ₹5,577.59 Lakhs . Key investor presentation takeaways from Devson Catalyst Ltd's Q1 FY27 investor presentation — and how it ranks against sector pee
- Ambani Orgochem (Q1 FY27)
Financial highlights show Total Income in ₹ Lakhs: . Key investor presentation takeaways from Ambani Orgochem's Q1 FY27 investor presentation — and how it ranks
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Galaxy Surfactants Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Galaxy Surfactants Ltd Q1 FY27 results?
Volume growth guidance maintained at 6% to 8% for full year FY26-27. Galaxy Surfactants expects volume growth of 6% to 8% annually going forward.
What is Galaxy Surfactants Ltd share price analysis?
Galaxy Surfactants Ltd currently shows a neutral. The stock trades at a P/E of 24.4 with a market cap of ₹8,872 Cr. Investors should review the full earnings analysis for detailed insights.
Is Galaxy Surfactants Ltd planning capital expenditure?
Galaxy Surfactants plans a capex of about INR 150 crores for the current year, similar to the previous year.
Keep Galaxy Surfactants Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.